Page 1 of Clinical Trials for de novo renal transplant recipient, 134 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
Last Updated: April 28, 2012
Condition(s): Chronic Allograft Nephropathy
2
Completed
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
Last Updated: January 26, 2011
Condition(s): Kidney Transplantation
3
Completed
A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients
Last Updated: March 25, 2011
Condition(s): Renal Transplantation
4
Completed
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids
Last Updated: January 28, 2011
Condition(s): Denovo Renal Transplantation
5
Completed
Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
Last Updated: May 17, 2011
Condition(s): Transplantation Infection
6
Completed
Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.
Last Updated: November 1, 2011
Condition(s): Kidney de Novo Transplant
7
Recruiting
Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients
Last Updated: April 28, 2012
Condition(s): Renal Interstitial Fibrosis
8
Recruiting
Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
Last Updated: April 28, 2012
Condition(s): Renal Transplantation
9
Not yet recruiting
Pharmacodynamics, Efficacy, Safety of Basiliximab 40 or 80 mg Combined With CsA or Everolimus, in Low Risk de Novo Renal Transplant Recipients
Last Updated: March 1, 2012
Condition(s): Renal Transplantation
10
Completed
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Last Updated: August 10, 2011
Condition(s): Kidney Transplantation
11
Completed
Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients
Last Updated: November 1, 2011
Condition(s): Renal Transplant
12
Completed
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
Last Updated: November 1, 2011
Condition(s): Renal Transplantation
13
Active, not recruiting
Extension Study to CRAD001A1202
Last Updated: April 28, 2012
Condition(s): Renal Transplant
14
Completed
An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens
Last Updated: August 16, 2010
Condition(s): Comparative Study; Immunosuppressive Agents
15
Active, not recruiting
Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients
Last Updated: November 29, 2011
Condition(s): Kidney Transplantation
16
Recruiting
Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients
Last Updated: April 28, 2012
Condition(s): Renal Transplantation
17
Completed
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
Last Updated: February 11, 2009
Condition(s): De Novo Renal Transplant Recipient.
18
Recruiting
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Last Updated: May 8, 2012
Condition(s): Renal Transplantation
19
Completed
Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)
Last Updated: November 1, 2011
Condition(s): Renal Transplantation
20
Completed
Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients
Last Updated: June 29, 2010
Condition(s): Kidney Transplantation

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=de+novo+renal+transplant+recipient

Page 1 of Clinical Trials for de novo renal transplant recipient, 134 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About